The hybrid ablation treatment developed at Maastricht UMC+ leads to better results in persistent atrial fibrillation than the standard treatment, catheter ablation.
Someone with diabetes has an increased risk of depression, but may be able to limit it by addressing risk factors such as unhealthy diet and high blood pressure. This has emerged from research by scientists at Maastricht UMC+ who analyzed data from nearly 78,000 people.
